tetano
Editor, Senior Moderator
Tuberc Respir Dis (Seoul). 2016 Apr;79(2):70-3. doi: 10.4046/trd.2016.79.2.70. Epub 2016 Mar 31.
[h=1]The 2009 H1N1 Pandemic Influenza in Korea.[/h] Kim JY[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] In late March of 2009, an outbreak of influenza in Mexico, was eventually identified as H1N1 influenza A. In June 2009, the World Health Organization raised a pandemic alert to the highest level. More than 214 countries have reported confirmed cases of pandemic H1N1 influenza A. In Korea, the first case of pandemic influenza A/H1N1 infection was reported on May 2, 2009. Between May 2009 and August 2010, 750,000 cases of pandemic influenza A/H1N1 were confirmed by laboratory test. The H1N1-related death toll was estimated to reach 252 individuals. Almost one billion cases of influenza occurs globally every year, resulting in 300,000 to 500,000 deaths. Influenza vaccination induces virus-neutralizing antibodies, mainly against hemagglutinin, which provide protection from invading virus. New quadrivalent inactivated influenza vaccine generates similar immune responses against the three influenza strains contained in two types of trivalent vaccines and superior responses against the additional B strain.
[h=4]KEYWORDS:[/h] Influenza; Pandemic; Vaccines
PMID: 27066083 [PubMed]
[h=1]The 2009 H1N1 Pandemic Influenza in Korea.[/h] Kim JY[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] In late March of 2009, an outbreak of influenza in Mexico, was eventually identified as H1N1 influenza A. In June 2009, the World Health Organization raised a pandemic alert to the highest level. More than 214 countries have reported confirmed cases of pandemic H1N1 influenza A. In Korea, the first case of pandemic influenza A/H1N1 infection was reported on May 2, 2009. Between May 2009 and August 2010, 750,000 cases of pandemic influenza A/H1N1 were confirmed by laboratory test. The H1N1-related death toll was estimated to reach 252 individuals. Almost one billion cases of influenza occurs globally every year, resulting in 300,000 to 500,000 deaths. Influenza vaccination induces virus-neutralizing antibodies, mainly against hemagglutinin, which provide protection from invading virus. New quadrivalent inactivated influenza vaccine generates similar immune responses against the three influenza strains contained in two types of trivalent vaccines and superior responses against the additional B strain.
[h=4]KEYWORDS:[/h] Influenza; Pandemic; Vaccines
PMID: 27066083 [PubMed]